4//SEC Filing
Sheridan William P 4
Accession 0001127602-22-009124
CIK 0000882796other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:21 PM ET
Size
10.1 KB
Accession
0001127602-22-009124
Insider Transaction Report
Form 4
Sheridan William P
SR VP - CMO
Transactions
- Exercise/Conversion
Common Stock
2022-03-10$3.22/sh+148,302$477,532→ 199,093 total - Sale
Common Stock
2022-03-10$16.87/sh−159,739$2,694,797→ 39,354 total - Sale
Common Stock
2022-03-10$17.64/sh−1,400$24,696→ 37,954 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2022-03-10−148,302→ 0 totalExercise: $3.22From: 2017-05-23Exp: 2026-05-23→ Common Stock (148,302 underlying)
Footnotes (2)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.53 to $17.52. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F2]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.53 to $17.79. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001439174
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:21 PM ET
- Size
- 10.1 KB